Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab 2024-02-09 11:22
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe 2023-12-01 03:53
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule 2023-09-06 19:00
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept 2023-07-24 18:30
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash 2022-02-28 22:15
1